Page last updated: 2024-08-22

angiotensin ii and Conjunctivitis

angiotensin ii has been researched along with Conjunctivitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Le, R; Shen, L; Yang, X; Ye, H	1

Other Studies

1 other study(ies) available for angiotensin ii and Conjunctivitis

Article	Year
Isoliquiritigenin protects against angiotensin II-induced fibrogenesis by inhibiting NF-κB/PPARγ inflammatory pathway in human Tenon's capsule fibroblasts. Experimental eye research, 2020, Volume: 199 Topics: Aldehyde Reductase; Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Chalcones; Conjunctiva; Conjunctivitis; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Humans; Male; Mice; Middle Aged; NF-kappa B; PPAR gamma; RNA, Messenger; Signal Transduction; Tenon Capsule; Trabeculectomy; Vasoconstrictor Agents	2020

Article

Year

Isoliquiritigenin protects against angiotensin II-induced fibrogenesis by inhibiting NF-κB/PPARγ inflammatory pathway in human Tenon's capsule fibroblasts.

Experimental eye research, 2020, Volume: 199

Topics: Aldehyde Reductase; Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Chalcones; Conjunctiva; Conjunctivitis; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Humans; Male; Mice; Middle Aged; NF-kappa B; PPAR gamma; RNA, Messenger; Signal Transduction; Tenon Capsule; Trabeculectomy; Vasoconstrictor Agents

2020